Email ID
Password
Sign me in automatically next time
clinica
Market Sector - IVDs
28 July 2011
Boston Scientific has continued to grow during its second fiscal quarter, helping to allay concerns sparked by CEO Ray Elliott's planned departure. He announced in May that he intends to retire at the end of the year, fuelling fears that the ...
26 July 2011
Kathleen Danenberg has quit her position as CEO of personalised medicine firm Response Genetics, but will stay at the company as executive scientific and technology officer. Ms Danenberg will also remain on Response's board of directors. The ...
26 July 2011
Oral fluid diagnostics specialist OraSure Technologies has gained a foothold in the molecular diagnostics market by agreeing to acquire DNA Genotek for $53m in cash. OraSure estimates that the segment is worth $4bn, and is growing rapidly. The move ...
26 July 2011
The NHS reform in England wends its way ever onwards. The “pause” is well in the background and the NHS Future Forum has delivered its verdict, but there is much more debate to come before Royal assent is granted to the troubled Health and Social ...
26 July 2011
Two genetic tests that had promised a breakthrough in the screening and confirmatory diagnosis of familial hypercholesterolaemia (FH) do not demonstrate sufficient clinical- or cost-effectiveness for use in the UK’s NHS, according to provisional ...
 
19 July 2011
As of this edition, Clinica’s Patent Watch has changed its focus to medtech areas which are witnessing fast growth. These include regenerative medicine, drug delivery and emerging areas within personalised medicine such as molecular diagnostics. New ...
 
12 January 2011
The clinical diagnostics market is one of the largest segments of the global medical device and diagnostics industry, ranking third in 2009 after surgical/medical instruments and surgical appliances/supplies. Sales of clinical diagnostics products ...
28 January 2010
Screening programmes to detect cancer in its early stages came under the spotlight last year as healthcare providers sought to restrict their reach, causing public outrage. Madeleine Armstrong considers the pros and cons of screening for breast, ...
HPV and the C word 18 September 2009

The human papilloma virus (HPV) screening-versus-vaccination debate has died down of late. But in the current economic crisis, with much of the world facing the need to keep public spending in check for years to come, we should expect it to ...

 
23 April 2009
Background: Molecular diagnostics is the application of molecular biology techniques and the knowledge of the molecular basis of diseases for diagnosis, prognostication or decision on therapeutic interventions. When the analyzed samples are tissues ...
23 April 2009
Background: Lung cancer is one of the leading causes of cancer-related deaths. Several diagnostic strategies are available but these are frequently ineffective, either because of their cost and organizational difficulty or because of the involvement ...
23 April 2009
Background: Proteomics has evolved into a large-scale biomarker discovery program; however, these initiatives are viewed as failing owing to a lack of successful implementation of new protein biomarkers in the diagnostic arena. New approaches to ...
 
 
COMPANY/ORGANISATION


Loading COMPANY/ORGANISATION ....
 
CONDITION


Loading CONDITION ....
 
GEOGRAPHY


Loading GEOGRAPHY ....
 
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36